AL
AMRI

Airain Ltd’s Albany Molecular Research Inc AMRI Stock Holding History

Airain Ltd’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,341
Closed -$483K – 1212
2015
Q4 		$483K Buy
+24,341
New +$463K 0.03% 470
2014
Q1 		– Sell
-35,185
Closed -$355K – 933
2013
Q4 		$355K Buy
+35,185
New +$425K 0.05% 377

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Airain Ltd's AMRI Position: Q1 2016 in Review

Airain Ltd sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 24,341 shares — an estimated $483K sold.

Airain Ltd first reported a position in AMRI in Q4 2013 and held it in 2 quarters. The position peaked at $483K in Q4 2015. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • Airain Ltd reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 24,341 Albany Molecular Research Inc shares in Q1 2016, an estimated $483K.
  • Airain Ltd first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 2 quarters.
  • Airain Ltd's Albany Molecular Research Inc position peaked at $483K in Q4 2015.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.